Tag: Stem Cells
FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host After Allo-HSCT
Ryoncil is first FDA-approved mesenchymal stromal cell therapy for pediatric patients aged 2 months or older
Itacitinib Helps Prevent Graft Versus Host Disease in Stem Cell Transplant Recipients
Itacitinib results in low cytokine release syndrome grades, low incidence of acute, chronic graft versus host disease
ASH: Auto-HCT Not Beneficial for Mantle Cell Lymphoma With Undetectable Residual Disease
Overall survival no better for those receiving autologous HCT plus maintenance rituximab versus rituximab alone
Overall Survival Improving for Umbilical Cord Blood Transplant
Inferior overall survival seen in Latine adults compared with Black patients in a multivariable analysis
Non-Hispanic Black Patients Have Disparities in HCT Use for Hematologic Cancers
For AML and MDS, lower utilization seen for non-Hispanic Black patients compared with other groups
Lung Function Stable Three Years After Hematopoietic Cell Transplant in Sickle Cell
Improvement seen in diffusing capacity of the lungs for carbon monoxide and in the six-minute walk test
FDA Approves Darzalex Faspro for Treating Multiple Myeloma
The quadruplet regimen was approved for stem cell transplant-eligible patients
Socioeconomic Status of Stem Cell Donor Affects Recipient Health Outcomes
Recipients receiving cells from donors in lowest quartile of SES experienced reduction in overall survival, increase in treatment-linked mortality
Successful Pregnancy Possible for Stem Cell Transplant Recipients
Annual first birth rate 0.45 percent, which was more than six times lower than in general population
Posttransplant Cyclophosphamide GVHD Prophylaxis Beneficial in Leukemia
PTCy GVHD prophylaxis after allogeneic stem cell transplant yields comparable relapse incidence, lower GVHD
